T1	Participants 86 195	intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients
T2	Participants 377 424	patients with aggressive non-Hodgkin's lymphoma
T3	Participants 718 811	patients in first complete remission with intermediate- and high-grade non-Hodgkin's lymphoma
T4	Participants 834 917	Patients were younger than 55 years and had at least one adverse prognostic factor.
T6	Participants 918 995	Induction treatment was that of the LNH84 protocol with an open randomization
T7	Participants 1018 1121	Patients in complete remission were further randomly assigned to receive either consolidation procedure
